176 related articles for article (PubMed ID: 11324698)
1. HLA, molecular mimicry and multiple sclerosis.
Liblau R; Gautam AM
Rev Immunogenet; 2000; 2(1):95-104. PubMed ID: 11324698
[TBL] [Abstract][Full Text] [Related]
2. DQB1*0602 allele shows a strong association with multiple sclerosis in patients in Malaga, Spain.
Fernández O; Fernández V; Alonso A; Caballero A; Luque G; Bravo M; León A; Mayorga C; Leyva L; de Ramón E
J Neurol; 2004 Apr; 251(4):440-4. PubMed ID: 15083289
[TBL] [Abstract][Full Text] [Related]
3. Antibodies against a class II HLA-peptide complex raised by active immunization of mice with antigen mimicking peptides.
Dam-Tuxen R; Riise E
Scand J Immunol; 2009 Aug; 70(2):93-100. PubMed ID: 19630914
[TBL] [Abstract][Full Text] [Related]
4. Association of HLA and multiple sclerosis.
Martin R; Vogt AB; Kropshofer H; Lichtenfels R
Behring Inst Mitt; 1994 Jul; (94):158-70. PubMed ID: 7998908
[TBL] [Abstract][Full Text] [Related]
5. Molecular mimicry and antigen-specific T cell responses in multiple sclerosis and chronic CNS Lyme disease.
Martin R; Gran B; Zhao Y; Markovic-Plese S; Bielekova B; Marques A; Sung MH; Hemmer B; Simon R; McFarland HF; Pinilla C
J Autoimmun; 2001 May; 16(3):187-92. PubMed ID: 11334482
[TBL] [Abstract][Full Text] [Related]
6. [Multiple sclerosis: molecular and cellular mechanisms].
Boĭko AN; Favorova OO
Mol Biol (Mosk); 1995; 29(4):727-49. PubMed ID: 7476940
[TBL] [Abstract][Full Text] [Related]
7. A functional and structural basis for TCR cross-reactivity in multiple sclerosis.
Lang HL; Jacobsen H; Ikemizu S; Andersson C; Harlos K; Madsen L; Hjorth P; Sondergaard L; Svejgaard A; Wucherpfennig K; Stuart DI; Bell JI; Jones EY; Fugger L
Nat Immunol; 2002 Oct; 3(10):940-3. PubMed ID: 12244309
[TBL] [Abstract][Full Text] [Related]
8. HLA-patterns in patients with multiple sclerosis and type I diabetes mellitus: evidence for possible mutual exclusion of both diseases.
Lobnig BM; Chantelau E; Vidgrén G; Van Landeghem AA; Kinnunen L; Tuomilehto-Wolf E
Diabetes Metab; 2002 Jun; 28(3):217-21. PubMed ID: 12149602
[TBL] [Abstract][Full Text] [Related]
9. Molecular mimicry in multiple sclerosis.
Sospedra M; Martin R
Autoimmunity; 2006 Feb; 39(1):3-8. PubMed ID: 16455577
[TBL] [Abstract][Full Text] [Related]
10. Degenerate T-cell receptor recognition, autoreactive cells, and the autoimmune response in multiple sclerosis.
Markovic-Plese S
Neuroscientist; 2009 Jun; 15(3):225-31. PubMed ID: 19297658
[TBL] [Abstract][Full Text] [Related]
11. Transmission of class I/II multi-locus MHC haplotypes and multiple sclerosis susceptibility: accounting for linkage disequilibrium.
Chao MJ; Barnardo MC; Lui GZ; Lincoln MR; Ramagopalan SV; Herrera BM; Dyment DA; Sadovnick AD; Ebers GC
Hum Mol Genet; 2007 Aug; 16(16):1951-8. PubMed ID: 17584771
[TBL] [Abstract][Full Text] [Related]
12. HLA-DRB1*1501, -DQB1*0301, -DQB1*0302, -DQB1*0602, and -DQB1*0603 alleles are associated with more severe disease outcome on MRI in patients with multiple sclerosis.
Zivadinov R; Uxa L; Bratina A; Bosco A; Srinivasaraghavan B; Minagar A; Ukmar M; Benedetto Sy; Zorzon M
Int Rev Neurobiol; 2007; 79():521-35. PubMed ID: 17531857
[TBL] [Abstract][Full Text] [Related]
13. [Immunogenetics of multiple sclerosis].
Clanet M; Cambon-Thomsen A; Rascol A
Pathol Biol (Paris); 1987 Mar; 35(3):299-302. PubMed ID: 3295695
[TBL] [Abstract][Full Text] [Related]
14. Specific central nervous system recruitment of HLA-G(+) regulatory T cells in multiple sclerosis.
Huang YH; Zozulya AL; Weidenfeller C; Metz I; Buck D; Toyka KV; Brück W; Wiendl H
Ann Neurol; 2009 Aug; 66(2):171-83. PubMed ID: 19705413
[TBL] [Abstract][Full Text] [Related]
15. Histocompatibility (HLA) antigens and multiple sclerosis in Israelis.
Brautbar C; Amar A; Cohen I; Kahana E; Cohen T; Bloch D; Grosse-Wilde H; Alter M
Isr J Med Sci; 1982 May; 18(5):631-4. PubMed ID: 7096048
[TBL] [Abstract][Full Text] [Related]
16. Multiple sclerosis and virus induced immune responses: autoimmunity can be primed by molecular mimicry and augmented by bystander activation.
McCoy L; Tsunoda I; Fujinami RS
Autoimmunity; 2006 Feb; 39(1):9-19. PubMed ID: 16455578
[TBL] [Abstract][Full Text] [Related]
17. Structural basis of molecular mimicry.
Wucherpfennig KW
J Autoimmun; 2001 May; 16(3):293-302. PubMed ID: 11334495
[TBL] [Abstract][Full Text] [Related]
18. Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis.
Barcellos LF; Sawcer S; Ramsay PP; Baranzini SE; Thomson G; Briggs F; Cree BC; Begovich AB; Villoslada P; Montalban X; Uccelli A; Savettieri G; Lincoln RR; DeLoa C; Haines JL; Pericak-Vance MA; Compston A; Hauser SL; Oksenberg JR
Hum Mol Genet; 2006 Sep; 15(18):2813-24. PubMed ID: 16905561
[TBL] [Abstract][Full Text] [Related]
19. The initiation of the autoimmune response in multiple sclerosis.
Markovic-Plese S; Pinilla C; Martin R
Clin Neurol Neurosurg; 2004 Jun; 106(3):218-22. PubMed ID: 15177771
[TBL] [Abstract][Full Text] [Related]
20. HLA-DRB5*0101 and -DRB1*1501 expression in the multiple sclerosis-associated HLA-DR15 haplotype.
Prat E; Tomaru U; Sabater L; Park DM; Granger R; Kruse N; Ohayon JM; Bettinotti MP; Martin R
J Neuroimmunol; 2005 Oct; 167(1-2):108-19. PubMed ID: 16111772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
